Rethinking clinical oncology drug research in an era of value‐based cancer care: A role for chemotherapy pathways-Reference-Cited by-同舟云学术

Rethinking clinical oncology drug research in an era of value‐based cancer care: A role for chemotherapy pathways

Published:2020-06-10 Issue:15 Volume:9 Page:5306-5311
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Hoverman J. Russell¹²^ORCID

Affiliation:

1. Value‐based Programs US Oncology/McKesson Specialty Health Texas Oncology Dallas TX USA

2. US Oncology/McKesson Specialty Health The Woodlands TX USA

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3193

Reference56 articles.

1. CMS.National Health Expenditures 2018 Highlights.https://www.cms.gov/files/documents/highlights.pdf. Accessed May 28 2020.

2. ASCO Post Staff.FDA Oncology drug approvals granted between May 21 2018 and May 14 2019.https:/www.ascopost.com/issues/june‐3‐2019‐narratives‐special‐issue/fda‐oncology‐drug‐approvals‐granted‐between‐may‐21‐2018‐and‐may‐14‐2019/. Accessed May 29 2020.

3. ShahA ed.Value‐based healthcare: a global assessment.www.renovatiobiomedica.com/wp‐content/uploads/2017/03/EIU_Medronic_Findings‐and‐Methodology.pdf. Accessed June 3 2020.

4. Characteristics of Oncology Clinical Trials

5. Evolution of the Randomized Controlled Trial in Oncology Over Three Decades

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How aging of the global population is changing oncology;ecancermedicalscience;2021-12-13

2. Affirming the Value of Clinical Chemotherapy Pathways Programs;JCO Oncology Practice;2021-08